Inventor · disambiguated record
Larry Fang
Also filed as: FANG LARRY · FANG LARRY Y · FANG LARRY YUN
3 granted patents·8 pending applications·23 citations·filing 2002–2021
62Inventor score
Files withSINOTHERAPEUTICS INC3ELAN PHARM INC2SCHERING CORP2ELAN PHARMACEUTICALS INC AND P1FANG LARRY YUN1
Top patents by PatentIndex Score
11 records- 0189US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 0265US7144897B2Hydroxy alkyl aminesELAN PHARM INC·Filed 2002·Granted Dec 5, 2006·2 cites·37 claims
- 0360US2011034478A1Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAsSCHERING PLOUGH CORP·Filed 2009·Application pending·0 cites
- 0453US2011123627A1High density compositions containing posaconazole and formulations comprising the sameFANG LARRY YUN·Filed 2009·Application pending·0 cites
- 0552US2007299263A1Hydroxy Alkyl AminesELAN PHARMACEUTICALS INC AND P·Filed 2006·Application pending·0 cites
- 0651US2023025316A1Olaparib pharmaceutical composition, formulation thereof, preparation method thereof and use thereofSINOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0749US2015150990A1ORAL PHARMACEUTICAL COMPOSITIONS IN A SOLID DISPERSION COMPRISING PREFERABLY POSACONAZOLE AND HPMCAsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 0848US2023055404A1Solid preparation, and preparation method therefor and use thereofSINOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0948US2009111831A1Pharmaceutical compositionsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1047US2005153976A1Pharmaceutical compositionsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1142US10391103B2Ferroporphyrin solid dispersion and preparation method thereofSINOTHERAPEUTICS INC·Filed 2014·Granted Aug 27, 2019·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Larry Fang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →